Combined tumour necrosis factor-alpha and tumour necrosis factor receptor genotypes could predict rheumatoid arthritis patients' response to anti-TNF-alpha therapy and explain controversies of studies based on a single polymorphism.
作者信息
Chatzikyriakidou A, Georgiou I, Voulgari P V, Venetsanopoulou A I, Drosos A A
出版信息
Rheumatology (Oxford). 2007 Jun;46(6):1034-5. doi: 10.1093/rheumatology/kem041. Epub 2007 Apr 4.
PMID:17409133
Abstract
摘要
Zotero 插件